Literature DB >> 28892954

Serum Free T3 to Free T4 Ratio as a Useful Indicator for Differentiating Destruction Induced Thyrotoxicosis from Graves' Disease.

Suman Baral1, Pradeep Krishna Shrestha2, Vivek Pant3.   

Abstract

INTRODUCTION: Thyrotoxicosis is a common disease encountered in Endocrine Outpatient Department (OPD). Two common causes of thyrotoxicosis are Destruction Induced Thyrotoxicosis (DIT) and Graves' Disease (GD). Differentiating DIT and GD based on clinical findings, is often not possible due to nonspecific symptoms. Thyroid scan is considered most reliable method for differentiating DIT and GD. AIM: To differentiate DIT and GD using the ratio of free triiodothyronine (fT3) and free thyroxine (fT4) thus avoiding thyroid technetium scan which is expensive and not accessible in developing countries like Nepal.
MATERIALS AND METHODS: Patients attending Endocrine OPD with diagnosis of thyrotoxicosis at their first visit in which Thyroid technetium scan could be done were taken as sample. The study was conducted from mid-June 2016 to February 2017 and total 55 samples were taken. Only selected cases were taken where diagnostic dilemma was present. Report of Thyroid Function Test (TFT) of patient at their first visit and findings of thyroid scan were recorded. Ratio of freeT3 and freeT4 was obtained in each case. ROC curve was plotted and the cut off value for differentiation of DIT and GD was obtained. All data were analysed using SPSS software version 20.0.
RESULTS: Mean ratio of fT3 to fT4 in GD and DIT was 0.395 and 0.287 respectively which was significant. On ROC analysis, cut off ratio for differentiating GD and DIT was 0.30 with sensitivity of 87% and specificity of 62.5%.
CONCLUSION: It is recommended that thyroid scan can be avoided if ratio of fT3 and fT4 is less than 0.3 and a diagnosis of DIT can be made.

Entities:  

Keywords:  Thyroid scan; fT3 (triiodothyronine); fT4 (thyroxine)

Year:  2017        PMID: 28892954      PMCID: PMC5583931          DOI: 10.7860/JCDR/2017/28293.10180

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.

Authors:  Rebecca S Bahn Chair; Henry B Burch; David S Cooper; Jeffrey R Garber; M Carol Greenlee; Irwin Klein; Peter Laurberg; I Ross McDougall; Victor M Montori; Scott A Rivkees; Douglas S Ross; Julie Ann Sosa; Marius N Stan
Journal:  Thyroid       Date:  2011-04-21       Impact factor: 6.568

2.  High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves' disease and silent thyroiditis.

Authors:  Tetsuya Hiraiwa; Mitsuru Ito; Akihisa Imagawa; Haruhiko Isotani; Junta Takamatsu; Kanji Kuma; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Thyroid       Date:  2004-07       Impact factor: 6.568

3.  Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.

Authors:  Jaeduk Yoshimura Noh; Naoko Momotani; Shuji Fukada; Koichi Ito; Akira Miyauchi; Nobuyuki Amino
Journal:  Endocr J       Date:  2005-10       Impact factor: 2.349

Review 4.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

5.  Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.

Authors:  Akane Ide; Nobuyuki Amino; Shino Kang; Waka Yoshioka; Takumi Kudo; Eijun Nishihara; Mitsuru Ito; Hirotoshi Nakamura; Akira Miyauchi
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

6.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid.

Authors:  D Salvatore; H Tu; J W Harney; P R Larsen
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 7.  Benign thyroid disease: what is the role of nuclear medicine?

Authors:  Salil D Sarkar
Journal:  Semin Nucl Med       Date:  2006-07       Impact factor: 4.446

8.  Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.

Authors:  Yukiko Izumi; Yoh Hidaka; Hisato Tada; Toru Takano; Taku Kashiwai; Ke-ita Tatsumi; Kiyoshi Ichihara; Nobuyuki Amino
Journal:  Clin Endocrinol (Oxf)       Date:  2002-07       Impact factor: 3.478

Review 9.  Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls.

Authors:  Joel R Smith; Elizabeth Oates
Journal:  Clin Nucl Med       Date:  2004-03       Impact factor: 7.794

10.  Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.

Authors:  Chutintorn Sriphrapradang; Adikan Bhasipol
Journal:  Ann Med Surg (Lond)       Date:  2016-08-08
View more
  3 in total

1.  Pregnancy exposure to common-detect organophosphate esters and phthalates and maternal thyroid function.

Authors:  Giehae Choi; Alexander P Keil; Gro D Villanger; David B Richardson; Julie L Daniels; Kate Hoffman; Amrit K Sakhi; Cathrine Thomsen; Amy H Herring; Samantha S M Drover; Rachel Nethery; Heidi Aase; Stephanie M Engel
Journal:  Sci Total Environ       Date:  2021-03-24       Impact factor: 10.753

2.  Rapid Differential Diagnosis of Thyrotoxicosis Using T3/T4 Ratio, FT3/FT4 Ratio and Color Doppler of Thyroid Gland.

Authors:  Rukma Rajendra Narkar; Ipsita Mishra; Anoj Kumar Baliarsinha; Arun Kumar Choudhury
Journal:  Indian J Endocrinol Metab       Date:  2021-10-26

3.  Time-dependent changes in FT4 and FT3 levels measured using mass spectrometry after an acute ingestion of excess levothyroxine in a case with hypothyroidism.

Authors:  Yuko Ito; Satoru Suzuki; Yoshiko Matsumoto; Chiyo Ohkouchi; Satoshi Suzuki; Manabu Iwadate; Sanae Midorikawa; Susumu Yokoya; Shinichi Suzuki; Hiroki Shimura
Journal:  Thyroid Res       Date:  2020-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.